• Chandan Guha

    Vice Chair Department of Radiation Oncology
    Albert Einstein College of Medicine

Chandan Guha, MBBS, PhD is Professor of Radiation Oncology and Pathology, Vice Chairman and the Director of Translational Research of the department of Radiation Oncology at Montefiore Medical Center, Albert Einstein College of Medicine, NY. His laboratory is investigating the effects of irradiation on normal tissue and stem cells. His group discovered that hepatic irradiation could be used as a preparative regimen for liver cell transplantation to promote repopulation of stem cells and adult hepatocytes in host liver. He has developed strategies for stem cell-based therapies to mitigate and treat radiation injury and to induce regeneration of irradiated organs, such as, liver, intestine and lung. He is currently the Director of the RadStem Center for Medical Countermeasures against Radiation and is the Founding Director of the Einstein Institute of Oncophysics. Dr. Guha is funded by multiple grants from the National Institute of Health and has collaborations with several Industrial partners to develop novel applications of radiation and ultrasound for tumor immunotherapy and regenerative medicine.

  • Richard Maughan

    Emeritus Professor CE of Radiation Oncology, Perelman School of Medicine
    University of Pennsylvania

  • Carl Rossi

    Medical Director
    Scripps Proton Therapy Center

  • John Chang

    Director of Clinical Research
    Northwestern Medicine Chicago Proton Center

  • Ben Wilkinson

    Medical Director
    Provision Center for Proton Therapy

  • Raymond Mailhot

    Radiation Oncology Resident
    NYU Langone Medical Center

  • Charles B. Simone

    Medical Director
    Maryland Proton Treatment Center

Charles B. Simone, II, MD, a nationally-recognized expert in proton therapy at the University of Pennsylvania, has been named the new Medical Director of the MPTC. Dr. Simone has been appointed Associate Professor in the UM SOM Department of Radiation Oncology. He is nationally recognized as an expert for the use of proton therapy in the treatment of thoracic malignancies, development of clinical trial strategies, and innovative research in thoracic radiation oncology. He chairs the Lung Committee of the Proton Collaborative Group, a national cooperative research coalition, is a member of the American Society for Radiation Oncology Lung Resource Panel, and a member of the NRG Oncology Lung Cancer Committee and the NRG Oncology Radiation Oncology Committee.